Understanding Extracellular Vesicles: The Body's Nano-Messengers

Extracellular vesicles (EVs) are nanoscale, membrane-bound particles that essentially every cell type releases into its surrounding environment. For decades after their discovery, researchers assumed they were little more than cellular debris. That assumption has been thoroughly overturned.

A landmark 2020 review in Science, one of the most widely cited papers in the field, reframes EVs as central mediators of intercellular communication — carrying proteins, lipids, and nucleic acids from a source cell to recipient cells, where that cargo can influence gene expression and cellular behavior. In effect, EVs let cells send targeted molecular messages to one another across the body, not just through direct contact but across distance.

EVs aren't a single, uniform category. The field currently distinguishes several subtypes based on size, biogenesis (how they form), and molecular composition. Exosomes — the smallest and most extensively studied subtype, typically 30 to 150 nanometers — form inside a cell through an internal budding process, are packaged into structures called multivesicular bodies, and are then released when those structures fuse with the cell's outer membrane. Larger vesicles, called microvesicles, instead bud directly outward from the plasma membrane. A third category, apoptotic bodies, is released when cells undergo programmed cell death.

Because "extracellular vesicle" research grew rapidly across many labs using inconsistent terminology, the International Society for Extracellular Vesicles published the MISEV guidelines — most recently updated as MISEV2023 — establishing standardized, experimentally verifiable criteria for how EVs should be defined, isolated, and characterized. This matters for anyone evaluating EV-related research: consistent terminology and methodology make it possible to actually compare results across different studies and labs.

What makes EVs particularly relevant to regenerative medicine is that a cell's EVs largely reflect that cell's own biological state and function. Mesenchymal stem cell-derived EVs, for example, carry a cargo of growth factors, anti-inflammatory signals, and regulatory microRNAs that can recapitulate much of the therapeutic signaling associated with the parent cells — without transplanting the cells themselves. That distinction, between the messenger and the source, is what underlies the broader shift toward cell-free regenerative approaches across the field.